| 摘要 |
<p>The present invention relates to the field of therapeutic chemistry, and in particular to new pharmaceutical compositions. It relates more especially to pharmaceutical compositions containing, by way of active principle, a spasmolytic agent of the musculotropic type or a ganglioplegic agent of the muscular type, in combination or mixed with an aqueous vehicle suitable for ocular administration. The pharmaceutical compositions according to the invention are used as a medicinal product for limiting, delaying or abolishing the effects of presbyopia.</p> |
